ALDH1A1 / ALDH1A2 / ALDH1A3 Antibody

Este producto es parte de ALDH - Aldehyde dehydrogenase family member
ALDH1A1 / ALDH1A2 / ALDH1A3 Antibody
260€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
ALDH1A1 / ALDH1A2 / ALDH1A3 Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx339967
Tested Applications
ELISA, WB, IHC

Description

ALDH1A1/ALDH1A2/ALDH1A3 Antibody is a Rabbit Polyclonal against ALDH1A1/ALDH1A2/ALDH1A3.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: ALDH1A1/ALDH1A2/ALDH1A3
Immunogen: Fusion protein of human ALDH1A1/ALDH1A2/ALDH1A3.
Host
Rabbit
Reactivity
Human
Recommended Dilution
ELISA: 1/1000 - 1/5000, WB: 1/500 - 1/1000, IHC: 1/20 - 1/50. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
PBS, pH 7.4, containing 0.05% NaN3 and 40% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P00352, O94788, P47895
Alias
3-deoxyglucosone dehydrogenase 1,ALDH-E1,ALHDII
Background
Antibody anti-ALDH1A1
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

ALDH1A1 is a cytosolic enzyme primarily responsible for catalyzing the oxidation of retinaldehyde to retinoic acid, a biologically active metabolite of vitamin A that regulates gene expression via retinoic acid receptors (RARs). ALDH1A1 plays a pivotal role in embryonic development, cell differentiation, and tissue regeneration, particularly in the eyes, liver, and hematopoietic systems. It is a well-known marker for cancer stem cells (CSCs) in various tumors, including breast, lung, and prostate cancers, where its overexpression contributes to chemoresistance, metastasis, and tumor initiation. ALDH1A1 is also involved in detoxifying reactive aldehydes, such as 4-hydroxynonenal (4-HNE), providing protection against oxidative stress. Its role in maintaining stem cell populations and redox homeostasis highlights ALDH1A1 as a therapeutic target in oncology. Additionally, ALDH1A1 is implicated in alcohol metabolism and the development of alcohol-related liver diseases.